Skip to main content

Table 3 Response of SCNSL patients after induction therapy

From: Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

Response

Total

New disease

Refractory disease

Relapse disease

N = 19

%

N = 10

%

N = 5

%

N = 4

%

CR

11

57.9

7

70

2

40

2

50

PR

2

10.5

1

10

0

0

1

25

WBRT*

5

26.3

2

20

2

40

1

25

Death

1

5.3

0

0

1

20

0

0

  1. CR complete remission, PR partial remission, SD stable disease, PD progression disease, WBRT whole brain radiotherapy
  2. *WBRT indicated SCNSL who turned to WBRT during the induction treatment